BridgeMD
New treatment option for Smoking Cessation
Official title Remote Smoking Cessation in Hospitalized Cardiac Patients
ClinicalTrials.gov ID: NCT05738408
What this study is testing
- What it's testing
- The investigators are proposing to examine new strategies for helping patients hospitalized for an acute coronary event adhere to recommendations to quit smoking. The investigators are interested to see whether offering financial incentives for smoking cessation, combined with medications to ameliorate withdrawal, can significantly reduce smoking in a population for which continued smoking has disproportionately negative health effects.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients will be recruited if they:
- Hospitalization for an acute coronary event which includes myocardial infarction or coronary revascularization (percutaneous intervention or coronary...
- live within 30 miles of UVMMC and are \>18 years of age
- Current cigarette smoker (defined as reporting any use of cigarettes in the week before admission and \>5 cigarette/day on average over the past 3...
You likely can't join if
- Patients will be excluded if they have:
- severe dementia/Alzheimer's disease
- an active malignancy, excluding non-melanoma skin cancer or low-grade prostate cancer under active surveillance
- exercise limiting vascular or neuromuscular disease
- Non-English Speaking
- No reliable smart-phone
See the full eligibility criteria
- Patients will be recruited if they:
- Hospitalization for an acute coronary event which includes myocardial infarction or coronary revascularization (percutaneous intervention or coronary artery bypass)
- live within 30 miles of UVMMC and are \>18 years of age
- Current cigarette smoker (defined as reporting any use of cigarettes in the week before admission and \>5 cigarette/day on average over the past 3 months)
- Patients will be excluded if they have:
- severe dementia/Alzheimer's disease
- an active malignancy, excluding non-melanoma skin cancer or low-grade prostate cancer under active surveillance
- exercise limiting vascular or neuromuscular disease
- Non-English Speaking
- No reliable smart-phone
- Current, regular use of smokeless tobacco or other form of non-combusted tobacco
The study team makes the final eligibility decision.
Where it's taking place
- Burlington, Vermont, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Burlington, Vermont, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.